Citation Impact
Citing Papers
Multiple Hepatic Receptors Cooperate to Eliminate Secretory Mucins Aberrantly Entering the Bloodstream: Are Circulating Cancer Mucins the “Tip of the Iceberg”?
2006
Childhood Guillain-Barré Syndrome: Clinical and Electrophysiologic Features Predictive of Outcome
2001
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer
2005
Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF
2005
Alternative methods of interpreting quality of life data in advanced gastrointestinal cancer patients
2001
Gastric cancer
2016 Standout
Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
2011
Fatal Liver Failure Associated with Valproate Therapy in a Patient with Friedreich's Disease: Review of Valproate Hepatotoxicity in Adults
1999
Optimal chemotherapy for advanced gastric cancer: is there a global consensus?
2013
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial
1999
Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial
2010
Abiotic Stress Signaling and Responses in Plants
2016 Standout
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006 Standout
Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial
2010
A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer
2010
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Irinotecan in the treatment of gastric cancer
2003
A randomized phase-II trial comparing sequential and concurrent paclitaxel with oral or parenteral fluorinated pyrimidines for advanced or metastatic gastric cancer
2012
The T-box factor MLS-1 acts as a molecular switch during specification of nonstriated muscle in C. elegans
2002 StandoutNobel
Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis
2000
Mitochondrial diabetes mellitus: a review
1995
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Guillain-Barré syndrome
2016 Standout
A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology
2008 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Crohn's disease
2012 Standout
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
2017 Standout
Drug-Induced Hepatotoxicity
2003 Standout
Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study
2004
The ground state of embryonic stem cell self-renewal
2008 StandoutNature
Out-of-hospital cardiac arrest due to drowning: An Utstein Style report of 10 years of experience from St. Mary's Hospital
2009
Esophageal Cancer
2003 Standout
Neural-Tube Defects
1999 Standout
22q11.21 Deletion Syndromes: A Review of Proximal, Central, and Distal Deletions and Their Associated Features
2015 Standout
Chemotherapy for advanced gastric cancer
2010
Selenium and human health
2012 Standout
Teratogen update: Gestational effects of maternal hyperthermia due to febrile illnesses and resultant patterns of defects in humans
1998
Chemotherapy for advanced gastric cancer
2005
Colorectal cancer
2019 Standout
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016
Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer
2001
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation
2005
Ulcerative colitis
2012 Standout
Gastric cancer treatment guidelines in Japan
2002
Current concepts and controversies in surgery for IBD
2004
Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trials
2006
Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
2007 Standout
Crohn's disease
2016 Standout
Paclitaxel versus docetaxel for advanced gastric cancer: a randomized phase II trial in combination with infusional 5-fluorouracil
2006
Randomized phase II study of irinotecan, leucovorin and 5-fluorouracil (ILF) versus cisplatin plus ILF (PILF) combination chemotherapy for advanced gastric cancer
2007
Oesophageal carcinoma
2013 Standout
Oral chemotherapy: rationale and future directions.
1998
The Schizophrenia Phenotype in 22q11 Deletion Syndrome
2003
Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer
1996
Rethinking schizophrenia
2010 StandoutNature
Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial
2003
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
2010 Standout
Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases
2003
Guidelines for the management of oesophageal and gastric cancer
2011
Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)
2001
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
2012 Standout
A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction
2010
Progress in treatments for colorectal cancer peritoneal metastases during the years 2010–2015. A systematic review
2016
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
2007 Standout
Azathioprine or 6-Mercaptopurine Before Colectomy for Ulcerative Colitis Is Not Associated With Increased Postoperative Complications
2002
Gastric cancer
2020 Standout
Impact of chemotherapy on quality of life in patients with metastatic esophagogastric cancer
2010
Summary of current therapeutic options for peritoneal metastases from colorectal cancer
2012
Leigh syndrome: Clinical features and biochemical and DNA abnormalities
1996
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer
2011
Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer
2002
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
2008 Standout
Multicenter phase II study of capecitabine plus oxaliplatin as a first-line therapy in Chinese patients with advanced gastric cancer
2008
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
2004 Standout
Evaluation of Clinical Benefit of Chemotherapy in Patients with Upper Gastrointestinal Cancer
1998
Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer
2014
Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects
1999
Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie
2008
One Thousand Health-Related Quality-of-Life Estimates
2000
Guillain-Barré syndrome
2005 Standout
Endurance running and the evolution of Homo
2004 StandoutNature
Selenium and Intractable Epilepsy: Is There Any Correlation?
2006
Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: a randomized phase 3 trial
2015
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
2006
In Vitro Analysis of Mutations Causing Myoclonus Epilepsy with Ragged-Red Fibers in the Mitochondrial tRNALys Gene: Two Genotypes Produce Similar Phenotypes
1995
Review article: the natural history of postoperative C rohn's disease recurrence
2012
Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
2008
Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate Data
2006
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
2006 Standout
Randomized Multicenter Phase II Trial of a Biweekly Regimen of Fluorouracil and Leucovorin (LV5FU2), LV5FU2 Plus Cisplatin, or LV5FU2 Plus Irinotecan in Patients With Previously Untreated Metastatic Gastric Cancer: A Fédération Francophone de Cancérologie Digestive Group Study—FFCD 9803
2004
Aquaporins Contribute to ABA-Triggered Stomatal Closure through OST1-Mediated Phosphorylation
2015
Weekly Infusional High-Dose Fluorouracil (HD-FU), HD-FU Plus Folinic Acid (HD-FU/FA), or HD-FU/FA Plus Biweekly Cisplatin in Advanced Gastric Cancer: Randomized Phase II Trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft Internistische Onkologie
2007
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
DEXTRANS AND GLYCOGENS AS PARTICULATE TRACERS FOR STUDYING CAPILLARY PERMEABILITY
1971 StandoutNobel
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Chemotherapy for advanced gastric cancer
2017 Standout
Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis
2013
Mitochondrial Diseases in Man and Mouse
1999 StandoutScience
De Gramont Schedule is a Very Low Toxic and Effective Regimen in Low Performance Status Patients Affected by Metastatic Gastric Cancer: Preliminary Report
2002
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
Phase II Multi-Institutional Randomized Trial of Docetaxel Plus Cisplatin With or Without Fluorouracil in Patients With Untreated, Advanced Gastric, or Gastroesophageal Adenocarcinoma
2005
Final Results of a Randomized Phase III Trial of Sequential High-Dose Methotrexate, Fluorouracil, and Doxorubicin Versus Etoposide, Leucovorin, and Fluorouracil Versus Infusional Fluorouracil and Cisplatin in Advanced Gastric Cancer: A Trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group
2000
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer
2008
Identification of Mechanism-Based Inactivation in P450-Catalyzed Cyclopropanation Facilitates Engineering of Improved Enzymes
2016 StandoutNobel
Brain evolution inHomo:The “radiator” theory
1990
Objective Responses in Patients with Malignant Melanoma or Renal Cell Cancer in Early Clinical Studies Do Not Predict Regulatory Approval
2005
Exchange of heme among hemoglobin molecules.
1966
High Doses of 5-Fluorouracil and Epirubicin with or without Cisplatin in Advanced Gastric Cancer: A Randomized Study
1999
Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Individual Patient Data
2004
A histochemical study of the distribution and fate of dextran in tissues of the mouse.
2003
Part 14: Pediatric Advanced Life Support
2010 Standout
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Prospective Randomized Trial Comparing Mitomycin, Cisplatin, and Protracted Venous-Infusion Fluorouracil (PVI 5-FU) With Epirubicin, Cisplatin, and PVI 5-FU in Advanced Esophagogastric Cancer
2002
Quality of Life With Docetaxel Plus Cisplatin and Fluorouracil Compared With Cisplatin and Fluorouracil From a Phase III Trial for Advanced Gastric or Gastroesophageal Adenocarcinoma: The V-325 Study Group
2007
Clinical Benefit With Docetaxel Plus Fluorouracil and Cisplatin Compared With Cisplatin and Fluorouracil in a Phase III Trial of Advanced Gastric or Gastroesophageal Adenocarcinoma: The V-325 Study Group
2007
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of W. Graf being referenced
Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer
1995
Bolus injection (2–4min) versus short-term (10–20min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trial
1998
Intraoperative hyperthermic versus postoperative normothermic intraperitoneal chemotherapy for colonic peritoneal carcinomatosis: a case–control study
2011
Kinetic analyses of plant water relocation using deuterium as tracer – reduced water flux of Arabidopsis pip2 aquaporin knockout mutants
2010
Uptake of 5-fluorouracil (5-FU) in peritoneal metastases in relation to the route of drug administration and tumour debulking surgery
2003
Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: Prognosis and treatment of recurrences in a cohort study
2012
Factors influencing recurrence in Crohn's disease
1996
Identification of Copy Number Variants on Human Chromosome 22 in Patients with a Variety of Clinical Findings
2011
Plasma Homocysteine and Methionine Concentrations in Children with Neural Tube Defects
1996
Free radicals, anticonvulsants, and the neuronal ceroid‐lipofuscinoses
1995
Phenotypic heterogeneity in families with the myoclonic epilepsy and ragged‐red fiber disease point mutation in mitochondrial DNA
1993
Altered Antioxidant Enzyme Activities in Children with a Serious Adverse Experience Related to Valproic Acid Therapy
1998
Genomic disorders on chromosome 22
2012
Predicting Outcome in Pediatric Submersion Victims
1995
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer
1997
Uptake of hyaluronan in hepatic metastases after blocking of liver endothelial cell receptors
1998
The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer
1994
Uterine Contraction in the Development of Möbius Syndrome
1997
Catecholamines in patients with 22q11.2 deletion syndrome and the low-activity COMT polymorphism
2001
A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children
1999
Outcome in severe pediatric Guillain-Barre syndrome after immunotherapy or supportive care
1999
On the Histochemistry of Partly Hydrolysed, Bacterial Dextran
1951
Factors influencing the functional outcome of restorative proctocolectomy in ulcerative colitis
2000
Prognosis after surgery in patients with incurable rectal cancer: A population-based study
1996
Patterns of human liver temperature.
1959
[STUDIES ON THE REVERSIBLE CONVERSION OF HEMOGLOBINS AND MYOGLOBINS INTO HEMOCHROMOGENS OR PARAHEMATINS BY NEUTRAL SALTS].
1963
Clinical features associated with the A → G transition at nucleotide 8344 of mtDNA (“MERRF mutation”)
1993